Despite the rapid growth of Korea’s biopharmaceutical market, the government's approval system to support it still relies on ...

ABL Bio has built a new headquarters in Gangnam, Seoul, anchoring its "Vision ABL 2.0."In an interview with Korea Biomedical ...

AstraZeneca Korea is expanding the therapeutic footprint of its PARP inhibitor Lynparza (ingredient: olaparib) in gynecologic ...

The mortality rate after acute myocardial infarction (AMI) was found to be higher among self-employed insured individuals ...

Just two months after German pharma Boehringer Ingelheim secured long-delayed reimbursement for Ofev in Korea, generics are ...

Inventage Lab unveiled its next-generation obesity drug platform technology in a poster presentation at the American Diabetes ...

Calls are growing to establish a new public medical school in South Jeolla Province, as promised by President Lee Jae ...

Calcium is a mineral that plays an essential role in life support, including heartbeat, muscle contraction, and nerve ...

The Ministry of Food and Drug Safety has approved an expanded indication for Vemlidy (ingredient: tenofovir alafenamide), ...

The rift among resigned doctors has been widening since the new government took office.A day after Park Dan, head of the ...

Korea’s Vaxcellbio is joining the next wave of cell therapy contenders, backed by a government grant and a platform it says ...

Siemens Healthineers Korea has signed a strategic memorandum of understanding (MOU) with Phantomics, a Korean cardiac imaging ...